As of 11:46am ET
| -3.33 / -3.84%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 54.00, with a high estimate of 59.00 and a low estimate of 46.00. The median estimate represents a -35.23% decrease from the last price of 83.37.
The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.